tadalafil has been researched along with Persistent Fetal Circulation Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, J; Song, LL; van den Anker, J; Wu, YE; Yang, XY; Zhang, W; Zhao, W | 1 |
1 review(s) available for tadalafil and Persistent Fetal Circulation Syndrome
| Article | Year |
|---|---|
Oral drugs used to treat persistent pulmonary hypertension of the newborn.
Topics: Administration, Oral; Antihypertensive Agents; Bosentan; Humans; Infant, Newborn; Off-Label Use; Persistent Fetal Circulation Syndrome; Randomized Controlled Trials as Topic; Sildenafil Citrate; Tadalafil | 2020 |